Skip to main content
G3: Genes | Genomes | Genetics logoLink to G3: Genes | Genomes | Genetics
. 2014 Nov 5;5(1):9–19. doi: 10.1534/g3.114.015354

In Silico Scrutiny of Genes Revealing Phylogenetic Congruence with Clinical Prevalence or Tropism Properties of Chlamydia trachomatis Strains

Rita Ferreira *,1, Minia Antelo *,1, Alexandra Nunes *,, Vítor Borges *,, Vera Damião *, Maria José Borrego *, João Paulo Gomes *,†,2
PMCID: PMC4291473  PMID: 25378473

Abstract

Microbes possess a multiplicity of virulence factors that confer them the ability to specifically infect distinct biological niches. Contrary to what is known for other bacteria, for the obligate intracellular human pathogen Chlamydia trachomatis, the knowledge of the molecular basis underlying serovars’ tissue specificity is scarce. We examined all ~900 genes to evaluate the association between individual phylogenies and cell-appetence or ecological success of C. trachomatis strains. Only ~1% of the genes presented a tree topology showing the segregation of all three disease groups (ocular, urogenital, and lymphatic) into three well-supported clades. Approximately 28% of the genes, which include the majority of the genes encoding putative type III secretion system effectors and Inc proteins, present a phylogenetic tree where only lymphogranuloma venereum strains form a clade. Similarly, an exclusive phylogenetic segregation of the most prevalent genital serovars was observed for 61 proteins. Curiously, these serovars are phylogenetically cosegregated with the lymphogranuloma venereum serovars for ~20% of the genes. Some clade-specific pseudogenes were identified (novel findings include the conserved hypothetical protein CT037 and the predicted α-hemolysin CT473), suggesting their putative expendability for the infection of particular niches. Approximately 3.5% of the genes revealed a significant overrepresentation of nonsynonymous mutations, and the majority encode proteins that directly interact with the host. Overall, this in silico scrutiny of genes whose phylogeny is congruent with clinical prevalence or tissue specificity of C. trachomatis strains may constitute an important database of putative targets for future functional studies to evaluate their biological role in chlamydial infections.

Keywords: Chlamydia trachomatis, genomics, clinical prevalence, tropism, loci


The observation that there are pathogenic and nonpathogenic microbes has compelled investigators to search for traits underlying their phenotypic differences. This search for the so called “virulence factors” has greatly contributed to the understanding of pathogenicity and to the elucidation of the genetic mechanisms underlying microbes’ capability to infect different cell types or organs. The notion that microbial pathogenicity relies on the interaction between a pathogen and its host (or a specific tissue), and that a virulence factor is either a microbial product or a strategy capable of causing damage to a susceptible host, can be broadly applied (Casadevall and Pirofski 2009). In this perspective, virulence factors may involve an endless list of products and mechanisms, such as toxins, adhesins, motility structures like flagella and pili, immune evasion determinants, capsules, biofilms, secretion systems, and signal transduction mechanisms (reviewed in Casadevall and Pirofski 2009). Usually, microbes carry several of these virulence factors, which work together in the process of host invasion and microbe survival.

Among pathogenic agents, several bacteria present intracellular lifestyles (obligatory or facultative). Their host-cell targets range from epithelial cells to phagocytes, like macrophages and neutrophils (Wilson et al. 2002), which implies that these pathogens have been developing specialized strategies that allow them, for instance, to survive within or avoid the adverse environment of the macrophage phagosome (membrane-bound vacuole) (Garcia-Del Portillo and Finlay 1995; Pizarro-Cerdá et al. 1997). Whereas some bacteria (e.g., Salmonella spp, Coxiella burnetii, and Cryptococcus neoformans) are able to reside within the lysosomal vacuole, others (e.g., Chlamydia trachomatis and Mycobacterium spp) need to “remodel” it to allow their survival, whereas others (e.g., Listeria monocytogenes and Shigella spp) degrade the vacuole membrane to gain access to the host-cell cytosol, where they may complete their developmental cycle (Pizarro-Cerdá et al. 1997; Ernst et al. 1999). Moreover, some pathogenic bacteria are also able to infect different cell types or organs of a given host. For example, L. monocytogenes can cross the intestinal epithelium, the blood–brain, and fetoplacental barriers (Cossart 2011) and may cause severe septicemia and meningoencephalitis (Allerberger and Wagner 2010), whereas Streptococcus pneumoniae is capable of infecting the lung, the blood, and the nasopharynx (Hava and Camilli 2002).

Another example of bacteria capable of infecting different cell types is C. trachomatis, an obligate intracellular human pathogen that can be classified into 15 main serovars, according to the polymorphism of the gene (ompA) encoding the major outer membrane protein. Serovars A-C cause ocular infections that can progress to trachoma, the leading cause of preventable blindness worldwide (Burton 2007; Wright et al. 2008), whereas serovars D-K cause ano-urogenital infections that can evolve to cervicitis, urethritis, epididymitis (men), or pelvic inflammatory disease (women), the latter of which can lead to significant long term sequelae such as infertility and ectopic pregnancy (Peipert 2003). Finally, serovars L1-L3 are responsible for an invasive disease, the lymphogranuloma venereum (LGV), through the infection of macrophages and dissemination to regional draining lymph nodes (Schachter 1978). Despite the huge phenotypic differences among C. trachomatis serovars regarding tissue tropism, virulence and ecological success, little is known about the molecular factors underlying serovars’ biological uniqueness. This is mostly due to the lack of suitable animal models that mirror the human chlamydial infection in vivo and because C. trachomatis has been genetically intractable until very recently (Kari et al. 2011; Wang et al. 2011; Mishra et al. 2012; Nguyen and Valdivia 2012). Probably the only unequivocal demonstration of the association of a virulence factor with tropism was provided by Caldwell et al. (2003), who showed that an active tryptophan operon (trpRBA) is mandatory for any C. trachomatis strain to infect the genitalia. This observation also was valid for genital strains harboring an “ocular” ompA gene (likely inherited by recombination), excluding the serovar status as a possible tropism determinant. Nevertheless, a revision concerning the genetics beyond tropism was recently published (Nunes et al. 2013).

Recent phylogenetic analysis (Harris et al. 2012) using the complete genome of several C. trachomatis strains found: i) the segregation of strains by their cell-appetence, suggesting a coevolution with the infected tissue; ii) the separation of the LGV strains before the separation of the ocular and the epithelial-genital strains; iii) that the most prevalent serovars (E and F), which account for ~50% of all chlamydial genital infections among the heterosexual population (Nunes et al. 2010), clearly segregate apart from the remainder epithelial-genital strains; and iv) that the ocular strains probably derived from a nonprevalent genital serovar. On the other hand, the small genome (~1 Mb) of C. trachomatis reveals a high degree of conservation among serovars (>98%), with nearly identical pan- and core-genomes, a high coding density, and no evidence of recent horizontal gene transfer besides allelic recombination, which suggests a likely complete genetic reduction process as a result of a long-term intracellular niche adaptation process (Horn et al. 2004; Read et al. 2013). Considering this, one may speculate that the phenotypic disparities (tissue tropism, virulence and ecological success) among strains are encoded in a small number of variable genes along the C. trachomatis genome. Thus, given the recent availability of dozens of C. trachomatis fully sequenced genomes, our main goal was to scrutinize all the ~900 genes at the phylogenetic and evolutionary level in order to better understand the relationship between strains’ genetic diversity and phenotypic disparities. In this regard, after analyzing the global trends of polymorphism, we performed a detailed analysis of each gene tree topology to assess the degree of concordance between strains’ segregation and their clinical outcome and prevalence. This approach intends to identify the genes that phylogenetically contribute for the main branches (LGV, prevalent genital, nonprevalent genital, and ocular serovars) of the species tree (Harris et al. 2012).

Materials and Methods

Alignments generation

For the polymorphism and evolutionary analyses, different alignment strategies were conducted. First, the whole-genome sequences of the 53 studied C. trachomatis strains were retrieved from the GenBank (Supporting Information, Table S1) and aligned using progressiveMauve from Mauve software, version 2.3.1 (Darling et al. 2010). Orthologous genes were identified by Mauve and individual alignments of each one of the 896 genes (considering the total number of annotated genes on the available D/UW-3/CX sequence) were extracted from the whole-genome alignment. These alignments were subsequently uploaded into the Molecular Evolutionary Genetics Analysis software, version 5 (MEGA 5; http://www.megasoftware.net) (Tamura et al. 2011) and visually inspected for further correction (whenever needed) prior to evolutionary and genetic diversity analyses. A core-alignment was also extracted by keeping regions where the 53 genomes aligned over at least 500 bp (corresponding of ~97% of the C. trachomatis chromosome), and aligned segments were concatenated into a single-core genome alignment to be further used in the construction of the species phylogenetic tree. This alignment was then exported and directly uploaded into MEGA 5 for whole-genome analyses purposes.

Exclusion criteria

Among all the 53 strains, variability in start codon predictions of homologous genes was removed by trimming each start site prediction to the innermost common start codon. This was not applied when an upstream codon was annotated as a consequence of a mutation in the codon correspondent to the translation initiation codon of the other sequences. We also observed that, for some other genes, there were strains that had more than one coding sequence annotated at the same region. These cases were treated as pseudogenes and the respective strains were removed from the analysis. There were also genes for which a single frameshift yielded a biased polymorphism, and for this reason they were not considered has truly polymorphic. Nevertheless, some of them (CT120, CT160, CT162, CT172, CT172.1, CT358, CT480.1, CT793, and CT852) constitute interesting cases as the frameshift occurred solely for the strains of the same disease group. Moreover, for 22 chromosomal genes, it was not possible to obtain an accurate alignment (Table S2) mainly because of accentuated gene size differences, hampering the analyses.

Polymorphism and evolutionary analyses

Each alignment (core-genome and individual genes) was analyzed according to previously described methods (Nunes et al. 2008; Almeida et al. 2012). Concerning the individual alignments of all homologous genes, we first removed from each analysis the strains’ sequences that were considered as putative pseudogenes or had annotation issues (see the section Exclusion criteria). By using the algorithms available in MEGA 5, we determined the overall mean distances (number of differences and p-distance) and matrices of pairwise comparisons at both nucleotide and amino acid level, along with the respective standard error estimates (bootstrap = 1000). Then, for each gene, the number of synonymous substitutions per synonymous site (dS) as well as the number of nonsynonymous substitutions per nonsynonymous site (dN) were determined by using the Kumar model (Nei and Kumar 2000) and the standard error estimates were obtained by a bootstrap procedure of 1000 replicates. dN/dS ratios were determined and the Z-test of positive selection was applied for the genes revealing dN/dS > 1. The probability of rejecting the null hypothesis of strict-neutrality (dN = dS) in favor of the alternative hypothesis of positive selection (dN > dS) was considered significant when P < 0.05 (bootstrap = 1000) (Nei and Kumar 2000). We also assessed the existence of correlation between p-distance and dN, dS, or dN/dS by using the Pearson’s Product Moment Correlation coefficient (R), which measures the strength and direction of a linear relationship between two variables (Rodgers and Nicewander 1988).

Phylogenetic trees for both the whole-genome and individual genes sequences were inferred by using the Neighbor-Joining method (bootstrap = 1000) (Felsenstein 1985; Saitou and Nei 1987). For the nucleotide sequences, the evolutionary distances were computed using the Kimura 2-parameter method (K2P) (Kimura 1980), whereas for the amino acid sequences (for individual genes solely), the evolutionary distances were computed based on the number of differences (Nei and Kumar 2000). A gene was considered to segregate a specific group of strains (ocular, genital and LGV serovars) by taking into account both the tree topology and the number of differences between sequences of different taxa. Additionally, phylogenies were also inspected for the segregation of the strains from the most prevalent genital serovars.

Characterization of the mosaic structure of the strains from the most prevalent serovars

We started by comparing the genome sequences of both D(s)/2923 and D/SotonD1 with that of the F/SW5 strain (because this strain was found to be the most closely related to both – see Results section) using the DNA polymorphism tool of the DnaSP software, version 5 (Librado and Rozas 2009), with a window size and step size of 1000 each. Chromosomal regions with high SNP density, which may indicate the occurrence of recombination events, were further analyzed by SimPlot/BootScan (http://sray.med.som.jhmi.edu/SCRoftware/simplot/) (Salminen et al. 1995;Lole et al. 1999) for a precise determination of potential mosaic structures. These analyses were performed as previously described (Gomes et al. 2007), using a sliding window size of 200 bp moved across the alignment in a step size of 30 bp for estimating pairwise genetic distances with Neighbor-Joining method (Kimura 2-parameter method; Bootstrap = 500; gaps strip off; ts/tv of 2.0). For BootScan analyses, the likelihood that the observed distribution of informative sites (Robertson et al. 1995) favoring specific phylogenetic groupings might occur randomly was assessed using the maximum χ2 test. A P-value for any specified breakpoint was determined by the Fisher’s exact test (two-tailed). A Bonferroni multiple correction testing was applied to evaluate the significance of the P-values at 95% confidence.

Results

Polymorphism and molecular evolution analysis

Overall, we were able to analyze ~97.5% (874/896) of all the C. trachomatis chromosomal genes. The 22 genes excluded from the analysis (see the section Exclusion criteria) comprise five housekeeping genes, the cytotoxin locus, genes encoding 13 hypothetical proteins, two of the phospholipase D endonuclease superfamily gene members (PLDs), and CT081 (Table S2).

Besides well-known polymorphic genes (CT870/pmpF, CT872/pmpH, CT681/ompA, CT049-CT051), the polymorphism analyses highlighted CT619 (Table 1 and Table S2) [coding for a putative type III secretion system (T3SS) secreted protein with unknown function] that, to our knowledge, had never been considered before as polymorphic.

Table 1. Top five ranking of the most polymorphic C. trachomatis chromosomal genes.

Rank Nucleotide
Amino Acid
No. Differences p-distance No. Differences p-distance
1 CT870/pmpF (217.3) CT681/ompA (0.121) CT870/pmpF (72.4) CT681/ompA (0.107)
2 CT681/ompA (143.7) CT051 (0.07) CT619 (48.4) CT051 (0.093)
3 CT619 (124.2) CT870/pmpF (0.069) CT051 (46.6) CT049 (0.08)
4 CT872/pmpH (109) CT049 (0.048) CT681/ompA (42.1) CT870/pmpF (0.071)
5 CT050 (104.9) CT619 (0.047) CT049 (38.9) CT050 (0.058)

The numbers in parenthesis refer to the respective number of differences and p-distance value.

To understand the underlying evolutionary pressures that drove amino acid changes of all 874 analyzed chromosomal proteins, we evaluated their molecular evolution by determining the dN/dS values of the respective genes. We verified that 150 genes (~17%) revealed a dN/dS > 1, but only 31 (3.5%) showed a significant Z-test of positive selection (Table S2) and were thus considered as putative targets of positive selection. Twenty-three of the latter encode 11 Inclusion Membrane Proteins (Incs), 10 T3SS effectors, and two putative membrane proteins, which are proteins expectedly involved in interactions with the host. We also found three hypothetical proteins encoding genes, one PLD encoding gene, and four housekeeping genes that are likely under positive selection. We have no reasonable explanation for the latter finding, as housekeeping genes are usually highly conserved and expected to be under purifying selection.

Furthermore, we evaluated the correlation between nucleotide polymorphism and evolutionary parameters, such as dN, dS, and dN/dS, for all 874 chromosomal genes. From the inspection of the genomic distribution of p-distance and dN/dS (Figure 1, A and B) and by determining the Pearson’s product moment correlation coefficient, we observed no correlation between them (R = 0.02), besides minor coincident peaks. Figure 1C highlights the 25 top ranked loci for both parameters. On the other hand, a strong positive linear correlation between p-distance and both dN (R = 0.92) and dS (R = 0.9) was found (Fig. 1D).

Figure 1.

Figure 1

Evaluation of the association between polymorphism and dN, dS and dN/dS. (A and B) Distribution of dN/dS and p-distance values, respectively, obtained from the analyses of all the 874 genes from the 53 strains. The horizontal axis represents the C. trachomatis chromosomal positions where genes are placed in their chromosomal order, from the CT001 to the CT875 (genes names and positions according to D/UW-3/CX strain annotation). (C) 25 genes (ordered by their relative chromosomal position) that display the greater values for both analyses, which are representative of the lack of correlation between dN/dS and polymorphism. (D) Scatter plots of p-distance vs. dN, dS, and dN/dS, on a log-scale for clarity. The Pearson’s product moment correlation coefficient for p-distance vs. dN, dS, and dN/dS are R = 0.92, R = 0.9, and R = 0.02, respectively.

Species polymorphism vs. number of taxa

Considering that the genetic diversity among same-serovar or same-disease group strains was recently pointed out to be higher than expected (Harris et al. 2012), we wonder whether both the polymorphism and selective pressure results are impacted by the number of sequences used. Thus, besides using all 53 strains, we also selected a group of 17 strains representative of the major branches of the phylogenetic tree constructed with the whole-genome sequences (Figure 2). Both groups of strains (17 vs. 53) encompass the same set of 13 C. trachomatis serovars. We then used the 100 most polymorphic genes (as they provide the vast majority of informative sites) and compared the distribution of polymorphism and dN/dS obtained from the analysis of the two groups (Figure 3). The P-values (paired two-tailed t-test) calculated for the p-distance and the dN/dS results were 0.91 and 0.13, respectively, which indicates that these parameters do not depend on the number of same-serovar sequences that are used. Although the validity of the traditional CT681/ompA typing has been strongly questioned (as its tree does not segregate strains by tissue tropism properties and disease outcomes) (Harris et al. 2012), it is worth noting that a small group of strains encompassing the majority of the C. trachomatis serovars represent the main genetic variability of this bacterium.

Figure 2.

Figure 2

Phylogenetic reconstruction of C. trachomatis species. The tree was constructed using the whole genome of 53 strains encompassing the majority of the CT681/ompA serovars. The asterisks indicate the 17 strains representative of the major tree branches (in red) that were used to evaluate the relation between species polymorphism and the number of taxa (see the section Results for details).

Figure 3.

Figure 3

Differences obtained during the analyses using 53 and 17 strains. The graphs show the differences obtained between the results of the p-distance (A) and the dN/dS (B) analyses of all the 53 and the set of 17 strains (representative of the majority of the tree branches). Each black dot represents one of the 100 polymorphic genes selected for these comparisons. P-values were calculated through the paired two-tailed t-test.

Gene-based phylogenetic analysis

To evaluate the concordance between strains’ segregation and their clinical outcome and prevalence, we first performed a detailed analysis of the recombination phenomena involving the two D strains (D(s)/2923 and D/SotonD1) that phylogenetically cluster with the most prevalent serovars (E and F) and apart from the other D strains (Jeffrey et al. 2010; Harris et al. 2012), in order to define their true genomic backbone. We verified that those D strains differ from the same serovar prototype strain (D/UW-3/CX) by ~5500 nucleotides, but differ from a serovar F strain (F/SW5) by only ~300 nucleotides, with ~50% of these mutations concentrated at the CT681/ompA region (Figure 4A). SimPlot and BootScan analyses identified the exact location of the two breakpoints underlying the recombination event (identical for both strains) (Figure S1). One breakpoint is located at the beginning of CT680/rpsB (P = 9.28 × 10−44) (Figure 4B), whereas the other is located at the beginning of CT681/ompA (P = 6.65 × 10−19) (Figure 4C). These results clearly indicate that both recombinant D strains have a genome backbone of a serovar F strain, whereas solely the region spanning between the two recombination breakpoints was inherited from a serovar D strain. Therefore, from now on these two D serovar strains will be included into the cluster of the most clinically prevalent serovars.

Figure 4.

Figure 4

Recombination analyses of the D(s)/2923 and D/SontonD1 strains. (A) Number of nucleotide differences (vertical axis) that exist between the genomic sequence of D(s)/2923 or D/SotonD1 and F/SW5. This polymorphism assessment was performed by using the DnaSP software, v5, with a window size and a step size of 1000 base pairs each. The smaller graph represents an enlarged view of the detected highly polymorphic region. (B) (first crossover) and (C) (second crossover) show the genes in each analyzed region (1) and also the results of the SimPlot (2), the BootScan (3), and the phylogenetic (4) analyses. Recombination breakpoints were individually analyzed because they were better mapped when a different outgroup strain was used for each one, i.e., the L3/404-LN for the first (B) and the C/TW-3 for the second (C) breakpoint. SimPlot graphs (2) show the level of similarity between the recombinant sequences and the respective parental strains (the number of informative sites supporting this relatedness are colored according to the graph legend box), whereas the BootScan graphs (3) show the phylogenetic relatedness (% of permuted trees) between those same sequences. Both analyses were obtained with a sliding window size of 200 bp and a step size of 30 bp. The sequence of the recombinant D strains was used as query. The vertical dashed black lines indicate the location of the estimated crossovers, shown in detail in Figure S1. Seventy-one informative sites support the similarity between the recombinant strain and F/SW5, whereas 76 support its similarity with D/UW-3/CX (P = 9.28 × 10−44). Forty-four informative sites support the similarity between the recombinant strain and D/UW-3/CX, whereas 25 support its similarity with F/SW5 (P = 6.65 × 10−19). In these defined regions there are no informative sites supporting the alternative hypotheses. The phylogenetic trees (4) were constructed with the nucleotide sequences adjacent to each estimated breakpoint region (NJ method; Kimura 2-parameter method; bootstrap = 1000) and support the recombination event.

To identify loci that phylogenetically contribute for the main branches of the species tree (Harris et al. 2012), we performed a detailed analysis of each gene phylogenetic tree. For clarification purposes, a gene/protein was considered to segregate a group of strains sharing a specific phenotype (ocular, prevalent genital, non-prevalent genital and LGV serovars) when the genetic differences among them are lower than the differences to any other strain. Overall, we found that 136, 14, 431, and 695 genes phylogenetically segregate the ocular, genital, prevalent genital and LGV groups, respectively (Figure 5A, Table 2, and Table S2). The low number of genes segregating the group of genital serovars reflects the high heterogeneity within this group as a direct consequence of the recombination background affecting mostly these strains (Harris et al. 2012) and the existence of distinct polymorphism signatures. An example of the latter stands for the F(s)/70 strain, which was isolated from the cervix and frequently showed a rather unusual polymorphism pattern that did not resemble any of the other 52 strains. Therefore, only 11 (1.3%) of nucleotide trees and 12 (1.4%) of protein trees were found to segregate strains by full-tropism (Figure 5A and Table 2), where ocular, LGV and all genital (prevalent and nonprevalent) serovar strains are segregated into three main clusters. In silico studies have already implicated some of these genes in the different cell-appetence of the strains, namely CT456/tarp, CT870/pmpF, CT872/pmpH, CT115/incD, CT116/incE, two PLD (CT156 and CT157), and one MACPF domain family protein (CT153) (Gomes et al. 2006; Thomson et al. 2008; Borges et al. 2012; Lutter et al. 2012). The remainders include three housekeeping genes (CT106/yceC, CT110/groEL1, and CT703/engA), and genes encoding one T3SS effector (CT161) (da Cunha et al. 2014) and one putative inclusion membrane protein (Inc) (CT383) (Dehoux et al. 2011) (Table S2).

Figure 5.

Figure 5

Genes that segregate strains according to their biological characteristics. The outer circle in both panels represents the genome of C. trachomatis D/UW-3/CX strain, where each bar represents a gene at its respective genomic position (light gray bars, forward strand; dark gray bars, reverse strand). (A) The tracks’ color scheme represent genes whose phylogeny segregates at least a group of strains according to their biological characteristics, i.e., each color illustrates a particular segregation (that may not be exclusive): full-tropism (purple), LGV strains (orange), strains from prevalent genital serovars (green), cosegregation of LGV and prevalent genital serovar strains (blue), genital strains (prevalent and nonprevalent serovars) (black), and ocular strains (red). (B) The tracks’ color scheme was maintained for the different groups of strains and represent genes that exclusively segregate a unique group of strains. For both panels, the outer and inner tracks of each color correspond to nucleotide and amino acid results, respectively.

Table 2. Number of genes/proteins that segregate C. trachomatis strains according to distinct phenotypes.

Segregation by Phenotypea
Exclusive Segregation by Phenotypeb
Full-tropismc Ocular Genitald Prevalent Genital Prevalent Genital + LGVe LGV Ocular Genitald Prevalent Genital LGV
Nucleotide 11 (1.3%) 136 (15.6%) 14 (1.6%) 431 (49.3%) 173 (19.8%) 695 (79.5%) 7 (0.8%) 0 (0%) 47 (5.4%) 245 (28%)
Amino acid 12 (1.4%) 105 (12%) 15 (1.7%) 302 (34.6%) 146 (16.7%) 531 (60.8%) 21 (2.4%) 1 (0.1%) 61 (7%) 240 (27.5%)

The numbers in parenthesis refer to the proportion of genes/proteins, found in each category, relative to the 874 analyzed genes/proteins. LGV, lymphogranuloma venereum.

a

Genes/proteins for which the phylogenetic tree differentiates at least one group of strains in a nonexclusive manner.

b

Genes/proteins for which the phylogenetic tree differentiates only one particular group of strains whereas the remainder are mixed.

c

Genes/proteins for which the phylogenetic tree shows three clades (ocular, genital, and LGV serovars).

d

Refers to all genital strains (prevalent plus non-prevalent serovars).

e

Genes/proteins for which the phylogenetic tree clusters the strains from prevalent genital and LGV serovars in the same clade.

We also detected events of exclusive phylogenetic segregation, i.e., the clustering of a particular group of strains sharing the same phenotype, whereas the remainder strains (regardless of their phenotype) are mixed together. For instance, the group of strains from the most prevalent genital serovars (E, F, and recombinant D strains) are exclusively segregated by 61 proteins, which may contain molecular features that contribute for their higher ecological success. We also observed that the most prevalent and the LGV serovars share hundreds of mutations, particularly in 173 genes (Table 2) revealing a major tree branch where these two groups co-segregate apart from the remaining strains. Concerning the LGV group, ∼28% of all chromosomal genes exclusively segregate these strains (Figure 5B), conferring this group a unique genetic make-up within the species diversity.

Also, based on either the presence of nonsense mutations or the considerable differences in gene size, we scrutinized the genome for the existence of genes that are putative pseudogenes exclusively for a specific disease group (Table 3). This set includes: i) CT058 [a putative Inc (Almeida et al. 2012)], CT105 [a T3SS effector possibly involved in the cell-appetence of the genital strains (Borges et al. 2012; da Cunha et al. 2014)], trpRBA operon (Caldwell et al. 2003), and CT374/aaxC (Giles et al. 2009), which are pseudogenes for most ocular strains; ii) CT101 [Inc (Almeida et al. 2012)] is a pseudogene for the majority of the genital strains; iii) CT473 (predicted α-hemolysin) is a pseudogene for the prevalent genital serovar strains; iv) CT373/aaxB (Giles et al. 2009) and CT300 [putative Inc (Dehoux et al. 2011)] are pseudogenes for LGV strains (Almeida et al. 2012) (for CT300, this occurs only if one considers the same start codon as that annotated for ocular and genital strains); and v) CT037 (conserved hypothetical protein) is a pseudogene for both prevalent genital and LGV serovars strains. This scenario suggests that these genes may be expendable for the C. trachomatis infection of specific biological niches.

Table 3. C. trachomatis known and putative pseudogenes for a particular disease group and genes that present differences in gene length among strains from different disease groups.

Gene Functional Category Strains Group
Observations Reference
Ocular Nonprevalent Genital Prevalent Genital LGV
CT037 HP = R Ψ Ψ A/2497, A/363, A/5291, and A/7249 are smaller than the nonprevalent genital serovars. This study
CT052 Coproporphyrinogen III oxidase > > = R This study
CT058 Putative inclusion membrane protein Ψ = = R A/Har13 and C/TW-3 are not Ψs. Almeida et al. 2012
CT101 Inclusion membrane protein = Ψ Ψ R E/Bour, E/11023, and D/UW3 are not Ψs. Almeida et al. 2012; This study
CT105 T3S effector Ψ = = R Borges et al. 2012
CT106 Predicted pseudouridine synthetase family = > > R This study
CT160 HP > > > R B/Jali20 is a Ψ, and F(s)/70 is smaller. This study
CT161 HP = < < R B/Jali20 and E/SotonE8 are Ψs. This study
CT162 HP < < < R E/SotonE8, F(s)/70, J/6276, Ia/SotonIa1, and Ia/SotonIa3 are Ψs. This study
CT171 Tryptophan synthase (alpha chain) Ψ = = R B/TZ is not a Ψ. Caldwell et al. 2003
CT172 HP < << << R This study
CT234 Membrane transport protein from the major facilitator superfamily = = < R This study
CT300 Putative inclusion membrane protein R = = Ψ Almeida et al. 2012
CT358 HP > > > R B/Jali20 is smaller. Almeida et al. 2012; Thomson et al. 2008
CT373 HP R = = Ψ Giles et al. 2009; This study
CT374 Arginine/ornithine antiporter Ψ = = R Giles et al. 2009; This study
CT392 HP > > > R This study
CT441 Tail-specific protease < < = R Ia/SotonIa1, Ia/SotonIa3, and J/6276 have the size of the LGV and prevalent genital serovars sequences. This study
CT470 HP = = > R This study
CT473 HP = = Ψ R This study
CT480.1 HP > > > R G/9301, G/9768, G/11074, J/6276, Ia/SotonIa1, and Ia/SotonIa3 are smaller than the remainder strains’ sequences. This study
CT522 S3 ribosomal protein = = < R This study
CT605 HP > > = R This study
CT793 HP > > > R G/9301, G/11074, and G/9768 are Ψs. This study
CT807 Glycerol-3-P acyltransferase < < = R This study
CT809 HP < < = R This study
CT833 Initiation factor 3 < < < R This study
CT852 YhgN family < < < R This study
CT868 Membrane thiol protease (predicted) > > > R This study

The differences in sequence length shown only refer to differences in termination between strains. Genes with discordant 5′ annotation, for which the correct start codon lacks confirmation, were not included. The differences in length do not contemplate indel events. LGV, lymphogranuloma venereum. Ψ, sequences considered as pseudogenes; R, the sequence whose size was used for reference purposes. LGV sequences were used by default except for LGV pseudogenes; =, gene of the same size as the reference; >, gene larger than the reference; <, gene smaller than the reference; <<, gene with the smallest size. Three sequence sizes were observed for CT172, depending on the disease group.

Discussion

Phylogenetic studies in C. trachomatis have been extensively performed on dozens of genes. Given the recent availability of more than 50 genomes, we sought to perform comparative genomics to examine all the ~900 C. trachomatis genes. We aimed to evaluate the degree of concordance between strains’ segregation and their clinical outcome and prevalence. In fact, the molecular basis underlying tissue specificity in C. trachomatis remains to be elucidated, although it is believed that it may rely on SNPs or small indel events in specific genes (Nunes et al. 2013), given the tremendous genome similarity (> 98%) among sequenced strains. It is known that there are biases associated with phylogenetic-based inferences (“phylogenetic dependence”), such as the weight of neutral mutations in the tree topology. Nevertheless, there are well-built examples in the literature where tree topology of C. trachomatis genes seems to be associated with niche specificity. This is the case of Tarp (Translocated actin-recruiting protein), for which distinct functional domains that are variable in number across serovars from different disease groups likely lead to differences in the host-cell actin-driven uptake of Chlamydia and to differential activation of diverse signaling pathways (like the Rac/WAVE2/Arp2/3 cascade and the humoral and cellular immune signaling pathways) (Clifton et al. 2004; Mehlitz et al. 2010; Carabeo 2011). Another relevant example is provided by most Incs, which may be associated with infection of mononuclear phagocytes due to the existence of specific mutational patterns leading to the phylogenetic segregation of LGV strains and to the higher expression of some Incs in these strains (Almeida et al. 2012; Lutter et al. 2012). In this regard, although our phylogenetic approach certainly carries associated biases, the identification of genes that phylogenetically contribute for the main branches (LGV, prevalent genital, non-prevalent genital and ocular serovars) of the species tree may be highly relevant for future functional studies.

Overall, only ~1.4% (12/874) of the proteins was found to present a plain segregation of strains according to their tissue tropism (ocular conjunctiva, genital epithelium, and lymph nodes). This low number is probably due to the existence of intra- and intergenic recombination events that take place during mixed infections [believed to occur at a frequency of approximately 1% (Clarke 2011)], essentially involving the genital strains (Harris et al. 2012). Although C. trachomatis is known to have a low population-level recombination rate based on the frequency and relative weight of recombination and mutation events (Joseph et al. 2011; Ferreira et al. 2012; Joseph et al. 2012), recombination has been detected, even among different disease-causing strains, and hotspots have been identified (Gomes et al. 2007; Harris et al. 2012). The biological role of some of these proteins has already been assessed (Nelson et al. 2006; Taylor et al. 2010; Derré et al. 2011), but with exception of the above cited Tarp, only a single serovar was tested, hampering any implication in tropism. On the other hand, it is possible that each of the corresponding genes is simply evolving more quickly than the genome average (quite likely due to host pressures).

A radically different scenario is found for the lymph nodes niche, as the majority of the genes (~80%) segregate the LGV strains and 28% (245/874) segregate them in an exclusive manner (Figure 5 and Table 2). This corroborates the early divergence of these strains (Stephens et al. 2009) and/or their fastest evolutionary nature. The latter hypothesis may rely on the fact that the LGV strains must be capable of establishing a wider set of molecular interactions and be subject to additional selective pressures, given their ability of infecting two distinct cell-types (epithelial and mononuclear phagocytes). It is worth noting that the majority of the genes encoding T3SS effectors and Incs (known and putative) segregate the LGV strains. One interesting example is CT144 that codes for a putative substrate of the T3SS (da Cunha et al. 2014) and is likely involved in the “men who have sex with men” epidemiological sexual network (Christerson et al. 2012), for which most of LGV-specific polymorphisms are concentrated in ~150 bp on the first half of the gene (Nunes et al. 2008), highlighting this specific region as the one hypothetically involved in the interaction with the host cell. Another example comes from the well-studied T3SS effector Tarp for which the enhanced phosphorylation found in LGV strains was shown to additionally promote high affinity interactions with proteins associated with the immune signaling pathways (Mehlitz et al. 2010), likely explaining the capacity of these strains to cross the mucosa epithelium and to infect mononuclear phagocytes.

We also observed that half of the C. trachomatis genes segregate strains of the most prevalent genital serovars, where 61 encode proteins displaying a mutational pattern that is exclusive of these strains. The majority of these genes (33/61) encode proteins that mediate basic cellular functions, like some redox reactions (CT078/folD, CT278/nqrB, CT539/trxA, and CT745/hemG), structural ribosomal proteins (CT125/rplM, CT506/rplQ, CT511, CT523/rplV, CT525/rplB, and CT787/rpsN) and proteins intervenient in the translation process (CT193/tgt, CT437/fusA, and CT851/map). However, given the high representation of these functional categories in C. trachomatis genome, we can hardly assume that specific metabolic functions underlie the higher clinical prevalence of strains from serovars E and F. Nevertheless, it seems clear that these serovars share a singular genomic makeup. In fact, two recombinant strains classified as serovar D that cluster in the same branch as E and F are actually F-like strains, and so, the branch of the most ecological succeeded serovars involve exclusively taxa with E or F backbone.

Curiously, we also found that 173 genes (19.8%) cosegregated the strains from the most prevalent genital serovars and the LGV strains. Some relevant examples refer to CT651, a possible virulence factor since it is under the regulation of C. trachomatis plasmid (Song et al. 2013), and CT338 and CT619, two T3SS substrates (Muschiol et al. 2011; da Cunha et al. 2014). Possible explanations for the existence of hundreds of shared polymorphisms between these two groups include: i) incomplete lineage sorting, where several unresolved polymorphisms would have been accumulated in the common ancestral before the clades’ separation of the current species tree (Galtier and Daubin 2008); ii) recombination, although it cannot fully explain this scenario as the genetic exchange between these two groups has been recently demonstrated to be restricted to limited genomic regions (Harris et al. 2012); and iii) short coevolutionary process between E/F and LGV strains before the separation of the latter. One may speculate that some of the shared polymorphisms could endow “invasive” properties to the most prevalent serovars strains. If that would be the case, it would mirror for instance the infection scenario of L. monocytogenes, which is capable of surviving within macrophages and also replicating in a variety of nonphagocytic cells (Pizarro-Cerdá et al. 2012). Therefore, one could hypothetically identify E or F strains during recent LGV outbreaks in Europe and USA. However, full-genome sequencing was not performed for all strains identified in those outbreaks and, to our knowledge, no E and F strains were identified so far. Thus, no immediate assumption can be made concerning specific phenotypes conferred by the related mutational pattern in those 173 genes between E/F and invasive strains.

We also identified several putative pseudogenes occurring in different strains (Table 3). The most interesting cases were the genes that were truncated only for strains of the same disease group, as it may be an indication of their expendability for the infection of a specific niche. We highlight the CT473, a lipid droplet-associated protein (Lda3) found to be translocated into the host cell cytoplasm and capture lipid droplets (Kumar et al. 2006), which is likely being lost on the course of the evolutionary process of the strains from prevalent genital serovars, and the CT037 (conserved hypothetical protein), which is a pseudogene in both the prevalent genital and LGV serovar strains. Although we have no clues about the importance of maintaining a functional protein in the clades where these genes are not pseudogenes, it was already demonstrated for example that a functional trpRBA operon is mandatory for any strain to infect the genitalia (Caldwell et al. 2003). Also, we have previously shown that the positively selected gene CT105 (a pseudogene for ocular strains) has a significant overrepresentation of nonsynonymous mutations when comparing sequences between urogenital and LGV strains (Borges et al. 2012), indicating that it has been evolutionarily diverging toward niche-specific adaptation. The identification of niche-specific pseudogenes may be indicative that further genome reduction may still be ongoing in C. trachomatis, leading to the future disappearance of those sequences from the chromosome. We also identified genes with differences in sequence length according to strains phenotype. For instance, both CT833 (translation initiation factor) and CT852 (integral membrane component) have longer sequences for all LGV strains, making them interesting targets for future evaluation, as the gene length may have a differential impact on the protein functionality. Additional analyses are now being performed at our lab in order to better characterize this complete set of genes (Table 3).

The analysis of polymorphism and dN/dS revealed no correlation between the two parameters, indicating that positive selection is highly targeted on specific genes or gene regions, or acts on strains with specific cell-appetence (Borges et al. 2012). Although our analysis was focused on whole genes (leading to an underestimation of positive selection), it is notable that the genes with significant dN/dS > 1 were mainly incs and T3SS effectors encoding genes, whereas the most polymorphic ones code essentially for membrane and hypothetical proteins. This seems to corroborate the assumption that proteins involved in strict pathogen-host interactions during the infection process are more prone to fix non-synonymous mutations, as previously reported in smaller scale studies (Almeida et al. 2012; Borges et al. 2012). On the other hand, polymorphism seems to be more pronounced in genes of other functional categories and may be due to discrete genetic drift, as most of the polymorphism is given by dS.

Finally, despite the controversial use of the traditional ompA-based typing method, it is worth noting that the main genetic variability within the C. trachomatis species is given by the different serovars, where additional strains from the same serovar contribute with few novel polymorphisms (driven either by drift or positive selection) that may impact the individual gene phylogenies (Figure 3).

As concluding remarks, our approach allowed the identification of genes that phylogenetically segregate strains according to specific phenotypes, namely the infection of the ocular tissue, the genitalia, the lymph nodes, as well as their clinical prevalence. It will certainly constitute an important database for prioritizing the targets for functional studies that are mandatory to clarify both their biological role and their involvement in tissue tropism, virulence and ecological success.

Supplementary Material

Supporting Information
supp_5_1_9__index.html (1.6KB, html)

Acknowledgments

This work was supported by a grant, ERA-PTG/0004/2010, from Fundação para a Ciência e a Tecnologia (FCT) (to J.P.G.), in the frame of ERA-NET PathoGenoMics. A.N. is recipient of a FCT post-doctoral fellowship (SFRH/BPD/75295/2010), V.B. and R.F. are recipients of Ph.D. fellowships (SFRH/BD/68527/2010 and SFRH/BD/68532/2010, respectively) from FCT, and V.D. is a recipient of fellowship on behalf of the grant ERA-PTG/0004/2010.

Footnotes

Supporting information is available online at http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.114.015354/-/DC1

Communicating editor: I. M. Hall

Literature Cited

  1. Allerberger F., Wagner M., 2010.  Listeriosis: a resurgent foodborne infection. Clin. Microbiol. Infect. 16: 16–23. [DOI] [PubMed] [Google Scholar]
  2. Almeida F., Borges V., Ferreira R., Borrego M. J., Gomes J. P., et al. , 2012.  Polymorphisms in Inc proteins and differential expression of inc genes among Chlamydia trachomatis strains correlate with invasiveness and tropism of lymphogranuloma venereum isolates. J. Bacteriol. 194: 6574–6585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Borges V., Nunes A., Ferreira R., Borrego M. J., Gomes J. P., 2012.  Directional evolution of Chlamydia trachomatis towards niche-specific adaptation. J. Bacteriol. 194: 6143–6153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Burton M. J., 2007.  Trachoma: an overview. Br. Med. Bull. 84: 99–116. [DOI] [PubMed] [Google Scholar]
  5. Caldwell H. D., Wood H., Crane D., Bailey R., Jones R. B., et al. , 2003.  Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. J. Clin. Invest. 111: 1757–1769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Carabeo R., 2011.  Bacterial subversion of host actin dynamics at the plasma membrane. Cell. Microbiol. 13: 1460–1469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Casadevall A., Pirofski L. A., 2009.  Virulence factos and their mechanism of action: the view from a damage-response framework. J. Water Health 7(Suppl 1): S2–S18. [DOI] [PubMed] [Google Scholar]
  8. Christerson L., Bom R. J., Bruisten S. M., Yass R., Hardick J., et al. , 2012.  Chlamydia trachomatis strains show specific clustering for men who have sex with men compared to heterosexual populations in Sweden, the Netherlands, and the United States. J. Clin. Microbiol. 50: 3548–3555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Clarke I. N., 2011.  Evolution of Chlamydia trachomatis. Ann. N. Y. Acad. Sci. 1230: E11–E18. [DOI] [PubMed] [Google Scholar]
  10. Clifton D. R., Fields K. A., Grieshaber S. S., Dooley C. A., Fischer E. R., et al. , 2004.  A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc. Natl. Acad. Sci. USA 101: 10166–10171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cossart P., 2011.  Illuminating the landscape of host-pathogen interactions with the bacterium Listeria monocytogenes. Proc. Natl. Acad. Sci. USA 108: 19484–19491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. da Cunha M., Milho C., Almeida F., Pais S. V., Borges V., et al. , 2014.  Identification of type III secretion substracts of Chlamydia trachomatis using Yersinia enterocolitica as a heterologous system. BMC Microbiol. 14: 40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Darling A. E., Mau B., Perna N. T., 2010.  progressiveMauve: Multiple genome alignment with gene gain, loss, and rearrangement. PLoS One 5: e11147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dehoux P., Flores R., Dauga C., Zhong G., Subtil A., 2011.  Multi-genome identification and characterization of chlamydiae-specific type III secretion substrates: the Inc proteins. BMC Genomics 12: 109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Derré I., Swiss R., Agaisse H., 2011.  The lipid transfer protein CERT interacts with the Chlamydia inclusion protein IncD and participates to ER-Chlamydia inclusion membrane contact sites. PLoS Pathog. 7: e1002092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ernst R. K., Guina T., Miller S. I., 1999.  How intracellular bacteria survive: surface modifications that promote resistance to host innate immune responses. J. Infect. Dis. 179(Suppl 2): S326–S330. [DOI] [PubMed] [Google Scholar]
  17. Felsenstein J., 1985.  Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39: 783–791. [DOI] [PubMed] [Google Scholar]
  18. Ferreira R., Borges V., Nunes A., Nogueira P. J., Borrego M. J., et al. , 2012.  Impact of genes nature on estimating recombination and mutation rates in Chlamydia trachomatis. G3 (Bethesda) 2: 761–768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Galtier N., Daubin V., 2008.  Dealing with incongruence in phylogenomic analyses. Philos. Trans. R. Soc. Lond. B Biol. Sci. 363: 4023–4029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Garcia-del Portillo F., Finlay B. B., 1995.  The varied lifestyles of intracellular pathogens within eukaryotic vacuolar compartments. Trends Microbiol. 3: 373–380. [DOI] [PubMed] [Google Scholar]
  21. Giles T. N., Fisher D. J., Graham D. E., 2009.  Independent inactivation of arginine decarboxylase genes by nonsense and missense mutations led to pseudogene formation in Chlamydia trachomatis serovar L2 and D strains. BMC Evol. Biol. 9: 166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Gomes J. P., Nunes A., Bruno W. J., Borrego M. J., Florindo C., et al. , 2006.  Polymorphisms in the nine polymorphic membrane proteins of Chlamydia trachomatis across all serovars: evidence for serovar Da recombination and correlation with tissue tropism. J. Bacteriol. 188: 275–286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Gomes J. P., Bruno W. J., Nunes A., Santos N., Florindo C., et al. , 2007.  Evolution of Chlamydia trachomatis diversity occurs by widespread interstrain recombination involving hotspots. Genome Res. 17: 50–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Harris S. R., Clarke I. N., Seth-Smith H. M., Solomon A. W., Cutcliffe L. T., et al. , 2012.  Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing. Nat. Genet. 44: 413–419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hava D. L., Camilli A., 2002.  Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol. Microbiol. 45: 1389–1406. [PMC free article] [PubMed] [Google Scholar]
  26. Horn M., Collingro A., Schmitz-Esser S., Beier C. L., Purkhold U., et al. , 2004.  Illuminating the evolutionary history of chlamydiae. Science 304: 728–730. [DOI] [PubMed] [Google Scholar]
  27. Jeffrey B. M., Suchland R. J., Quinn K. L., Davidson J. R., Stamm W. E., et al. , 2010.  Genome sequencing of recent clinical Chlamydia trachomatis strains identifies genes associated with tissue tropism and regions of apparent recombination. Infect. Immun. 78: 2544–2553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Joseph S. J., Didelot X., Gandhi K., Dean D., Read T. D., 2011.  Interplay of recombination and selection in the genomes of Chlamydia trachomatis. Biol. Direct 6: 28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Joseph S. J., Didelot X., Rothschild J., de Vries H. J., Morre S. A., et al. , 2012.  Population genomics of Chlamydia trachomatis: insights on drift, selection, recombination, and population structure. Mol. Biol. Evol. 29: 3933–3946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kari L., Goheen M. M., Randall L. B., Taylor L. D., Carlson J. H., et al. , 2011.  Generation of targeted Chlamydia trachomatis null mutants. Proc. Natl. Acad. Sci. USA 108: 7189–7193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Kimura M., 1980.  A simple method for estimating evolutionary rate of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol. 16: 111–120. [DOI] [PubMed] [Google Scholar]
  32. Kumar Y., Cocchiaro J., Valdivia R. H., 2006.  The obligate intracellular pathogen Chlamydia trachomatis targets host lipid droplets. Curr. Biol. 16: 1646–1651. [DOI] [PubMed] [Google Scholar]
  33. Librado P., Rozas J., 2009.  DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics 25: 1451–1452. [DOI] [PubMed] [Google Scholar]
  34. Lole K. S., Bollinger R. C., Paranjape R. S., Gadkari D., Kulkarni S. S., et al. , 1999.  Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J. Virol. 73: 152–160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Lutter E. I., Martens C., Hackstadt T., 2012.  Evolution and conservation of predicted inclusion membrane proteins in Chlamydiae. Comp. Funct. Genomics 2012: 362104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Mehlitz A., Banhart S., Maurer A. P., Kaushansky A., Gordus A. G., et al. , 2010.  Tarp regulates early Chlamydia-induced host cell survival through interactions with the human adaptor protein SHC1. J. Cell Biol. 190: 143–157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Mishra M. K., Gerard H. C., Whittum-Hudson J. A., Hudson A. P., Kannan R. M., 2012.  Dendrimer-enabled modulation of gene expression in Chlamydia trachomatis. Mol. Pharm. 9: 413–421. [DOI] [PubMed] [Google Scholar]
  38. Muschiol S., Boncompain G., Vromman F., Dehoux P., Normark S., et al. , 2011.  Identification of a family of effectors secreted by the type III secretion system that are conserved in pathogenic Chlamydiae. Infect. Immun. 79: 571–580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Nei M., Kumar S., 2000.  Molecular Evolution and Phylogenetics. Oxford University Press, New York, NY. [Google Scholar]
  40. Nelson D. E., Crane D. D., Taylor L. D., Dorward D. W., Goheen M. M., et al. , 2006.  Inhibition of Chlamydiae by primary alcohols correlates with the strainspecific complement of plasticity zone phospholipase D genes. Infect. Immun. 74: 73–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Nguyen B. D., Valdivia R. H., 2012.  Virulence determinants in the obligate intracellular pathogen Chlamydia trachomatis revealed by forward genetic approaches. Proc. Natl. Acad. Sci. USA 109: 1263–1268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Nunes A., Nogueira P. J., Borrego M. J., Gomes J. P., 2008.  Chlamydia trachomatis diversity viewed as a tissue-specific coevolutionary arms race. Genome Biol. 9: R153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Nunes A., Nogueira P. J., Borrego M. J., Gomes J. P., 2010.  Adaptive evolution of the Chlamydia trachomatis dominant antigen reveals distinct evolutionary scenarios for B- and T-cell epitopes: worldwide survey. PLoS One 5: e13171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Nunes A., Borrego M. J., Gomes J. P., 2013.  Genomic features beyond Chlamydia trachomatis phenotypes: what do we think we know? Infect. Genet. Evol. 16: 392–400. [DOI] [PubMed] [Google Scholar]
  45. Peipert J. F., 2003.  Clinical practice. Genital chlamydial infections. N. Engl. J. Med. 349: 2424–2430. [DOI] [PubMed] [Google Scholar]
  46. Pizarro-Cerdá J., Moreno E., Desjardins M., Gorvel J. P., 1997.  When intracellular pathogens invade the frontiers of cell biology and immunology. Histol. Histopathol. 12: 1027–1038. [PubMed] [Google Scholar]
  47. Pizarro-Cerdá J., Kühbacher A., Cossart P., 2012.  Entry of Listeria monocytogenes in mammalian epithelial cells: an updated view. Cold Spring Harb. Perspect. Med. 2: a010009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Read T. D., Joseph S. J., Didelot X., Liang B., Patel L., et al. , 2013.  Comparative analysis of Chlamydia psittaci genomes reveals the recent emergence of a pathogenic lineage with a broad host range. MBio 4: e00604–e00612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Robertson D. L., Hahn B. H., Sharp P. M., 1995.  Recombination in AIDS viruses. J. Mol. Evol. 40: 249–259. [DOI] [PubMed] [Google Scholar]
  50. Rodgers J. L., Nicewander W. A., 1988.  Thirteen ways to look at the correlation coefficient. Am. Stat. 42: 59–66. [Google Scholar]
  51. Saitou N., Nei M., 1987.  The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4: 406–425. [DOI] [PubMed] [Google Scholar]
  52. Salminen M. O., Carr J. K., Burke D. S., McCutchan F. E., 1995.  Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res. Hum. Retroviruses 11: 1423–1425. [DOI] [PubMed] [Google Scholar]
  53. Schachter J., 1978.  Chlamydial infections (first of three parts). N. Engl. J. Med. 298: 428–435. [DOI] [PubMed] [Google Scholar]
  54. Song L., Carlson J. H., Whitmire W. M., Kari L., Virtaneva K., et al. , 2013.  Chlamydia trachomatis plasmid-encoded Pgp4 is a transcriptional regulator of virulence-associated genes. Infect. Immun. 81: 636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Stephens R. S., Myers G., Eppinger M., Bavoil P. M., 2009.  Divergence without difference. phylogenetics and taxonomy of Chlamydia resolved. FEMS Immunol. Med. Microbiol. 55: 115–119. [DOI] [PubMed] [Google Scholar]
  56. Tamura K., Peterson D., Peterson N., Stecher G., Nei M., et al. , 2011.  MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28: 2731–2739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Taylor L. D., Nelson D. E., Dorward D. W., Whitmire W. M., Caldwell H. D., 2010.  Biological characterization of Chlamydia trachomatis plasticity zone MACPF domain family protein CT153. Infect. Immun. 78: 2691–2699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Thomson N. R., Holden M. T., Carder C., Lennard N., Lockey S. J., et al. , 2008.  Chlamydia trachomatis: genome sequence analysis of lymphogranuloma venereum isolates. Genome Res. 18: 161–171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Wang Y., Kahane S., Cutcliffe L. T., Skilton R. J., Lambden P. R., et al. , 2011.  Development of a transformation system for Chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector. PLoS Pathog. 7: e1002258 .10.1371/journal.ppat.1002258 [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Wilson J. W., Schurr M. J., LeBlanc C. L., Ramamurthy R., Buchanan K. L., et al. , 2002.  Mechanisms of bacterial pathogenicity. Postgrad. Med. J. 78: 216–224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Wright H. R., Turner A., Taylor H. R., 2008.  Trachoma. Lancet 371: 1945–1954. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information
supp_5_1_9__index.html (1.6KB, html)

Articles from G3: Genes|Genomes|Genetics are provided here courtesy of Oxford University Press

RESOURCES